Truist Financial Issues Positive Forecast for Astrana Health (NASDAQ:ASTH) Stock Price

Astrana Health (NASDAQ:ASTH) had its target price hoisted by Truist Financial from $37.00 to $38.00 in a research report report published on Friday,Benzinga reports. Truist Financial currently has a buy rating on the stock.

Several other research analysts have also commented on the company. Weiss Ratings reiterated a “sell (d+)” rating on shares of Astrana Health in a research report on Monday, December 29th. BTIG Research dropped their target price on Astrana Health from $45.00 to $40.00 and set a “buy” rating for the company in a report on Monday, February 2nd. Needham & Company LLC initiated coverage on Astrana Health in a report on Friday, December 12th. They set a “buy” rating and a $28.00 price target on the stock. Zacks Research raised shares of Astrana Health from a “strong sell” rating to a “hold” rating in a research note on Wednesday. Finally, Jefferies Financial Group reissued a “buy” rating on shares of Astrana Health in a research note on Tuesday, November 25th. Five research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $34.00.

Astrana Health Price Performance

Astrana Health stock opened at $24.26 on Friday. The company has a market cap of $1.37 billion, a price-to-earnings ratio of 52.74 and a beta of 0.91. The firm’s fifty day moving average is $23.46 and its 200 day moving average is $25.99. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.25. Astrana Health has a 52-week low of $18.08 and a 52-week high of $34.80.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings data on Monday, March 2nd. The company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.15 by $0.39. Astrana Health had a net margin of 0.71% and a return on equity of 5.59%. The business had revenue of $950.53 million during the quarter, compared to analyst estimates of $930.46 million. During the same quarter last year, the business earned ($0.15) earnings per share. Astrana Health’s quarterly revenue was up 42.9% compared to the same quarter last year. Sell-side analysts forecast that Astrana Health will post 1.15 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in ASTH. Royal Bank of Canada increased its stake in Astrana Health by 6.5% in the 1st quarter. Royal Bank of Canada now owns 278,619 shares of the company’s stock worth $8,640,000 after buying an additional 17,028 shares during the period. AQR Capital Management LLC purchased a new stake in Astrana Health in the 1st quarter valued at about $933,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Astrana Health by 5.2% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company’s stock worth $799,000 after acquiring an additional 1,263 shares in the last quarter. Jones Financial Companies Lllp grew its stake in Astrana Health by 4,365.2% in the 1st quarter. Jones Financial Companies Lllp now owns 11,163 shares of the company’s stock worth $346,000 after acquiring an additional 10,913 shares in the last quarter. Finally, Intech Investment Management LLC increased its position in shares of Astrana Health by 5.8% during the first quarter. Intech Investment Management LLC now owns 44,586 shares of the company’s stock worth $1,383,000 after acquiring an additional 2,462 shares during the period. 52.77% of the stock is currently owned by institutional investors.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.